Society Lecture: W(h)ither EVTs?

{alt_text}

Professor Kathleen Carroll

Albert E Kent Professor of Psychiatry

Kathleen Carroll, Ph.D., is a Professor of Psychiatry at the Yale University School of Medicine, Scientific Director of the Center for Psychotherapy Development at Yale, and Principal Investigator of the New England Node of the National Institute on Drug Abuse’s Clinical Trials Network. 

The author of over 190 journal articles, chapters and books Dr. Carroll's research and clinical interests lie in the area of developing, specifying and evaluating evidence-based treatments for substance use disorders.  Dr. Carroll is the Past President of Division 50 (Addictions) of the American Psychological Association, and currently holds both K05 (Senior Scientist) and MERIT awards from NIDA.  She received the Distinguished Scientific Contributions to Education and Training Award from Division 50 of the American Psychological Association

In addition to serving on numerous advisory boards and scientific review panels, Dr. Carroll is an Associate Editor of Psychological Assessment and serves on the editorial boards of multiple journals, including  Experimental and Clinical Psychopharmacology, Psychology of Addictive Behaviors, and The American Journal on Addictions.  



What is the future of manual guided therapies?  It is clear that the burgeoning number of empirically validated therapies for the addictions and related disorders are not being rapidly assimilated into clinical practice, and research has only begun to address some of the critical issues regarding the translation of empirically supported therapies to clinical practice.  To a large extent, efficacy studies have not addressed key translational issues such as the efficacy of empirically validated therapies with respect to standard practice or ‘clinicians choice’ models.   Data are also needed regarding the kind of training is needed by what kind of clinicians to effectively implement different kinds of therapies, or whether it is cost-effective to train clinicians at all.  Several alternate models of effectiveness research and strategies for bridging the gap between research and practice will be presented.


Downloads: